Agriculture›
Apparel and fashion accessories›
Construction & real estate›💡Electronic & Electrical›🍎Food & Beverages›🛋️Home furnishing & supplies›⚗️Industrial goods & chemical›🪨Minerals & metals›📦Miscellaneous›
Agriculture›
Apparel and fashion accessories›
Construction & real estate›💡Electronic & Electrical›🍎Food & Beverages›🛋️Home furnishing & supplies›⚗️Industrial goods & chemical›🪨Minerals & metals›📦Miscellaneous›

The Exosome Therapeutics Quality Control Solution is offered by Bertis Inc. in 1 ml vials with cold-chain packaging. It is a standardized exosome reference preparation containing defined amounts of protein, lipid, nucleic acid and metabolite components. The liquid reagent is ready-to-use and formulated to meet in-vitro diagnostic (IVD) regulatory requirements for clinical assay validation. Each vial is sealed to preserve stability during transport from the supplier’s facility in Gwacheon‑Si, Gyeonggi‑Do, South Korea.
Typical exosome reference materials are calibrated to a particle concentration of about 1 × 10⁹ particles per millilitre and a protein content near 1 mg ml⁻¹, values that enable consistent assay performance across laboratories. Standard storage conditions are -20 °C to -80 °C, with a documented shelf life of 12 months when kept frozen. The preparation exhibits a lipid concentration of roughly 0.5 mg ml⁻¹ and nucleic acid yields around 100 ng per vial, which align with common pan-omics benchmarking standards. These specifications are widely accepted as typical for quality‑control exosome reagents used in biomarker discovery and liquid‑biopsy development.
The solution is primarily used by research laboratories, diagnostic developers and pharmaceutical companies engaged in exosome‑based biomarker validation and therapeutic development. Importers and distributors supplying biotech firms or academic institutions constitute the main buyer segment. Packaging in single‑dose vials facilitates precise dosing and inventory control, while the supplier does not disclose a minimum order quantity, so prospective purchasers should request MOQ, incoterms and payment options directly from Bertis Inc.
| Material | Standardized exosome reference preparation |
| Vial volume | 1 ml |
| Packaging | Cold‑chain sealed vials |
| Regulatory compliance | Meets IVD regulatory standards |
| Particle concentration | typical 1 × 10⁹ particles per ml |
| Protein concentration | typical 1 mg ml⁻¹ |
| Lipid concentration | typical 0.5 mg ml⁻¹ |
| Nucleic acid yield | typical 100 ng per vial |
| Storage temperature | typical -20 °C to -80 °C |
| Shelf life | typical 12 months when frozen |
Bertis Inc. is located at 3rd Floor, B Building, 33, Gwacheon‑daero 7‑gil, Gwacheon‑Si, Gyeonggi‑Do, South Korea (Republic Of Korea). The company is listed with a harbour trust tier, indicating verified business credentials. Their profile shows a response rate of 0 % and no recorded average response time, which may require proactive communication from buyers.
The supplier specialises in providing biotech reagents and reference materials for exosome research and clinical diagnostics. Their catalogue includes the Exosome Therapeutics Quality Control Solution and related analytical services, but the listing does not disclose additional product lines, certifications or production capacity. Prospective buyers should request any required compliance documents such as ISO 13485 or specific IVD certificates directly from Bertis Inc.
This exosome therapeutics quality control solution is a ready-to-use liquid reagent designed for validation and quality assurance in clinical diagnostic workflows. Supplied as a standardized formulation in 1 mL vials with cold chain packaging, it supports biomarker discovery and liquid biopsy assay development. Essential for laboratories engaged in in vitro diagnostics, pharmaceutical research, and clinical trial biomarker validation, this product meets IVD regulatory standards and facilitates reproducible results in exosome-based disease detection applications.
| Business Type | Supplier |
| Year Established | Recently Joined |
| Employees | Contact Supplier |
| Annual Revenue | Contact Supplier |
| Main Products | View Products Tab |
| Major Markets | Global |
| Response Time | Contact Supplier |
| Response Rate | New Supplier |
Before initiating a purchase, importers should verify Bertis Inc.’s corporate registration and request any applicable quality certifications such as ISO 13485 or specific IVD certificates. Confirm that the exosome reference material complies with local regulatory frameworks, for example the Korean MFDS guidelines for diagnostic reagents, and ask for a detailed certificate of analysis. Validation of the supplier’s harbour trust tier and a recent financial reference can further mitigate commercial risk.
Shipping from Gwacheon‑Si typically involves air freight with temperature‑controlled containers to preserve the cold chain, although sea freight can be arranged for larger volumes. Common incoterms include FCA Seoul or CIF Busan; buyers should ask the supplier to provide an estimated dispatch window and transit time. Payment terms are usually negotiated as a letter of credit or advance payment, and confirming the preferred method early helps avoid delays. Request a packing list that records vial counts, batch numbers and storage temperature monitoring data.
Upon receipt, perform a visual inspection of the vial seals and verify the batch code against the supplier’s documentation. A representative sample should be thawed according to the supplier’s protocol and analysed for particle concentration, protein and lipid content to confirm that the material meets the typical specifications. Request the full material safety data sheet, certificate of analysis and a compliance statement referencing the relevant IVD standards. Keeping these records will support quality assurance and facilitate regulatory submissions throughout the product development lifecycle.
Active buying requirements from importers looking for Similar products
Compare alternatives, find similar products and connect with verified suppliers
When sourcing Exosome Therapeutics Quality Control Solution for your business, securing the right balance of quality and cost is essential. Bertis Inc., a verified supplier based in South Korea (Republic Of Korea), offers this product with key specifications including IVD-grade quality control standard / research use only formulation available, Defined concentration of exosomes with characterized protein, lipid, nucleic acid, and metabolite profile, and Ready-to-use liquid format; 1 mL vial standard packaging. By purchasing directly from the manufacturer or authorized exporter, buyers can negotiate favorable FOB prices starting at $6001,200./Unit and manage bulk orders with a minimum order quantity (MOQ) of 1 Unit. This product is actively traded under HS Code 3822.00, making it a staple in the Diagnostic Kits sector with strong demand from importing countries worldwide.
Importing Exosome Therapeutics Qual requires careful attention to shipping logistics, customs compliance, and secure payment terms. Bertis Inc. offers flexible shipping options such as Full Container Load (FCL) or Less than Container Load (LCL) via sea freight. To ensure a smooth transaction, buyers should verify import duties for HS Code 3822.00 in their destination country. Common payment methods for international B2B transactions include Letter of Credit (L/C), Telegraphic Transfer (T/T), and Documents against Payment (D/P). All transactions and RFQs are facilitated through EximNext, a leading global B2B marketplace designed to make cross-border trade secure and efficient.
Finding trustworthy partners is the foundation of successful importing. The supplier of this Exosome Therapeutics Qual has been verified on our platform. Whether you are a distributor, wholesaler, or procurement manager, you can request a free quotation, ask for product samples, and finalize your bulk purchase with confidence. EximNext hosts thousands of verified manufacturers and exporters across 200+ countries. Explore similar products in the Diagnostic Kits category and connect with top-tier exporters on our comprehensive import export marketplace. Start your sourcing journey today.
Importing Exosome Therapeutics Qual requires careful attention to shipping logistics, customs compliance, and secure payment terms. Common shipping options include Full Container Load (FCL) or Less than Container Load (LCL) via sea freight. Buyers should verify import duties for HS Code 3822.00 in their destination country. Common payment methods include Letter of Credit (L/C), Telegraphic Transfer (T/T), and Documents against Payment (D/P).
The current listed wholesale price for Exosome Therapeutics Quality Control Solution from Bertis Inc. is $6001,200./Unit on FOB terms from South Korea (Republic Of Korea). Prices may vary depending on order volume, packaging, and destination. For the most accurate bulk quote, send a direct RFQ to Bertis Inc. through EximNext.
The supplier, Bertis Inc., has set a Minimum Order Quantity (MOQ) of 1 Unit for Exosome Therapeutics Qual. For sample requests or smaller trial orders, contact the supplier directly through our platform's inquiry system.
For international shipping and customs clearance, Exosome Therapeutics Quality Control Solution is classified under HS Code 3822.00. Buyers should verify their local customs regulations to determine applicable import duties and taxes for this classification.
To import Exosome Therapeutics Qual from South Korea (Republic Of Korea), negotiate shipping terms (FOB, CIF, or EXW) directly with Bertis Inc.. Ensure you have the necessary import licenses for Diagnostic Kits products in your destination country.
Yes, Bertis Inc. is a verified supplier on EximNext. You can view their complete company profile, business registration details, certifications, and export history before placing a bulk order.
The key specifications for Exosome Therapeutics Quality Control Solution supplied by Bertis Inc. include IVD-grade quality control standard / research use only formulation available, Defined concentration of exosomes with characterized protein, lipid, nucleic acid, and metabolite profile, and Ready-to-use liquid format; 1 mL vial standard packaging. For a complete technical data sheet or Certificate of Analysis (COA), send an inquiry directly to the supplier through EximNext.
Bertis Inc. offers Exosome Therapeutics Qual with standard export packaging. Custom packaging, private labeling, and OEM/ODM options may also be available for large wholesale orders.
Exosome Therapeutics Qual is actively imported by buyers worldwide. Request a destination-specific CIF or CFR quote from Bertis Inc. through our platform.
Bertis Inc. maintains international quality certifications. These ensure that the Exosome Therapeutics Qual meets international quality, safety, and regulatory standards required for cross-border trade.
Click "Request Quotation" on this product page, specify your required quantity, preferred shipping terms, and destination country. Bertis Inc. will respond with a detailed wholesale quote including FOB pricing, lead time, and payment options.
Common payment methods include Letter of Credit (L/C), Telegraphic Transfer (T/T), Documents against Payment (D/P), and Escrow services. Confirm accepted terms directly with Bertis Inc..
Discover more products in Diagnostic Kits from verified suppliers worldwide.